Potential factors influencing initial sorafenib dose selection in hepatocellular carcinoma (HCC): U.S. regional analysis of GIDEON.
Bilal Piperdi
Honoraria - Celgene; Genentech/Roche; Pfizer
Allen Lee Cohn
Consultant or Advisory Role - Genentech; Genomic Health; Sanofi
Anthony B. El-Khoueiry
Consultant or Advisory Role - Bayer/Onyx
Research Funding - Astex Therapeutics; Bristol-Myers Squibb; Piramal; Roche
Jean-Francois Geschwind
Employment or Leadership Position - Prescience Labs
Consultant or Advisory Role - Bayer; Biocompatibles International; Delcath Systems ; Guerbet; Jennerex Biotherapeutics; Nordion; Prescience Labs
Stock Ownership - Prescience Labs
Research Funding - Bayer; Biocompatibles International; DOD; Guerbet; NCI-ECOG; NIH; Nordion; Philips Healthcare
Pierre Michel Gholam
Consultant or Advisory Role - Bayer/Onyx
Honoraria - Bayer/Onyx
Research Funding - Bayer/Onyx
Parvez Mantry
Consultant or Advisory Role - Bayer; Gilead Sciences; Merck; Vertex
Honoraria - Celgene; Genentech/Roche; Pfizer
Research Funding - AbbVie; Boehringer Ingelheim; Gilead Sciences; Salix Pharmaceuticals; Santaris; Vertex; Vital Therapies
Robert C. G. Martin
Consultant or Advisory Role - Bayer/Onyx
Brendan McGuire
Research Funding - Bayer; Cumberland Pharmaceuticals; Ikaria; Vertex
Rebecca A. Miksad
Consultant or Advisory Role - Advance Medical; OptumInsight
Research Funding - Bayer/Onyx; Daiichi Sankyo; ImClone Systems; Newlink Genetics; Sanofi
Arun J. Sanyal
Consultant or Advisory Role - Abbott Laboratories; Bristol-Myers Squibb; GENFIT; Gilead Sciences; Ikaria; Merck; Nitto Denko; Norgine; Roche; Salix Pharmaceuticals; Takeda
Research Funding - Astellas Pharma; Exalenz Bioscience; Galectin Therapeutics; Genentech; Gilead Sciences; Gore; Ikaria; Intercept Pharmaceuticals; Novartis; Salix Pharmaceuticals ; Takeda
Alan Paul Venook
No relevant relationships to disclose
Svetlana Babajanyan
Employment or Leadership Position - Bayer
Stock Ownership - Bayer
Alec Goldenberg
Consultant or Advisory Role - Saladax Biomedical